Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents-Reference-Cited by-同舟云学术

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents

Published:2020-09-01 Issue:9 Volume:174 Page:882
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Castagnoli Riccardo¹²,Votto Martina¹²,Licari Amelia¹²,Brambilla Ilaria¹,Bruno Raffaele²³,Perlini Stefano⁴,Rovida Francesca⁵,Baldanti Fausto²⁵,Marseglia Gian Luigi¹²

Affiliation:

1. Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

2. Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

3. Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

4. Emergency Medicine, Department of Internal Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

5. Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology, and Child Health

Link

https://jamanetwork.com/journals/jamapediatrics/articlepdf/2765169/jamapediatrics_castagnoli_2020_rv_200005_1598544887.48635.pdf

Reference43 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China.;Guan;N Engl J Med

2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.;Lu;Lancet,2020

3. A novel coronavirus from patients with pneumonia in China, 2019.;Zhu;N Engl J Med,2020

4. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.;Xu;Nat Med

5. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.;Hoffmann;Cell

Cited by 875 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years;JAMA;2024-02-06

2. Characteristics and Outcomes of Children With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Admitted to a Quaternary Hospital: A Single-Center Experience;Cureus;2024-01-18

3. Prevalence of sleep disturbances in children and adolescents during COVID-19 pandemic: a meta-analysis and systematic review of epidemiological surveys;Translational Psychiatry;2024-01-08

4. Mental health and quality of life in children and adolescents during the COVID-19 pandemic: a systematic review of longitudinal studies;Frontiers in Public Health;2024-01-08

5. Gold single atom-based aptananozyme as an ultrasensitive and selective colorimetric probe for detection of thrombin and C-reactive protein;Microchimica Acta;2023-12-28